Cell Therapy News/Articles, page-61

Investors like Madam will wait until MSB clears the bar and are prepared to pay a premium for lower risk. Others (like me) will choose a discount for higher risk. No right or wrong - just is.

@zrod13107 ,

Yes, we all have different tolerance for risk.

But when you say "No right or wrong - just is", bear in mind that there is a large body of research in the field of behavioural finance demonstrating that investors greatly tend to overstate the potential returns on offer, while at the same time greatly under-estimating the risks.

And nowhere will you find clearer demonstration of this human condition than in the many thousands of posts on HotCopper, including in relation to MSB where - for years - an array of posters have expressed nothing but bullish sentiments of hope along the lines of "the next few weeks/months/year will be when MSB's potential is finally recognised by the market".